Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Teva Pharmaceutical Industries ADR Representing One TEVA

Healthcare Biotechnology
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:TEVA)

Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March

GlobeNewswire March 3, 2025

2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals

GlobeNewswire February 27, 2025

Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY(R) (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder

GlobeNewswire February 25, 2025

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn's Disease

GlobeNewswire February 22, 2025

Teva and Alvotech Announce SELARSDI(TM) (ustekinumab-aekn) Injection Now Available in the U.S.

GlobeNewswire February 21, 2025

Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO)

GlobeNewswire February 18, 2025

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

GlobeNewswire February 18, 2025

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

GlobeNewswire February 18, 2025

Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth

GlobeNewswire January 29, 2025
View More News ››

Opinion & Analysis (NYSE:TEVA)

Gilead, Teva, XPhyto - Global marketing potential

Stockhouse Editorial June 16, 2020

The ASX: investing in an emerging biotech frontier

The Life Sciences Report August 10, 2016

An ETF That Provides Shelter From Stormy Markets

Benzinga.com  September 3, 2015

Buy biotech when there's blood on the street: Pontifax's Ran Nussbaum

George S. Mack September 3, 2015

Teva's Deal-Making Spurs Inflows To Israel ETFs

Benzinga.com  August 3, 2015

ETFs For The Next Pharma Takeover Candidates

Benzinga.com  July 28, 2015
View More Opinion ››

Bullboard Posts (NYSE:TEVA)

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) Climbs to N

Breaking News: $TEVA Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) Climbs to New 52-Week HighShares of Teva Pharmaceutical Industries...
whytestocks - December 17, 2024

Teva Announces Strong Growth in Second Quarter Revenues main

Breaking News: $TEVA Teva Announces Strong Growth in Second Quarter Revenues mainly driven by Generics Products in All Regions and...
whytestocks - July 31, 2024

Teva Reports First Quarter 2024 Financial Results and Reaffi

News; $TEVA Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial OutlookFor an accessible version of this...
whytestocks - May 8, 2024

Teva Reports Growth in Fourth Quarter and Full Year 2023

Just In: $TEVA Teva Reports Growth in Fourth Quarter and Full Year 20232023 revenues of $15.8 billion reflect an increase of 7% in local...
whytestocks - January 31, 2024

Opiates

<< View Post To Watch Video >>
Joe455 - December 30, 2021

Back in...

Lost a bit on this a few years ago, but bought back in this week at levels below what I had sold at, largely to crystalize the loss. I...
Paddy902 - April 28, 2019
View more Bullboard ››

Cizzle Brands Corp.

Cizzle Brands Corp.

Cizzle Brands Corporation is a Canada-based consumer-packaged goods company. The Company's activities consist of developing ...
View More »